Webb5 maj 2024 · Selected key stats of Paratek Pharmaceuticals, Inc. (PRTK) including 10 year stock price and latest news. Key stats provide selected financials for rapid company overview including revenues, marketcap, P/E ratio, debt and much more. WebbPRTK (Paratek Pharmaceuticals) Beneish M-Score as of today (March 15, 2024) is -2.71. Beneish M-Score explanation, calculation, ... PRTK) Ownership Structure Tell Us Something Useful? By Yahoo Finance 2024-07-18 Paratek Pharmaceuticals Announces Inclusion of NUZYRA (omadacycline) in Chinas National Reimbursement Drug List (NRDL)
Institutions profited after Paratek Pharmaceuticals, Inc.
WebbPRTK - Paratek Pharmaceuticals, Inc. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart … Webb11 apr. 2024 · The current PRTK price target is $10.00. Learn why top analysts are making this price prediction for Paratek Pharmaceuticals at MarketBeat. Skip to main content. S&P 500 . DOW . QQQ 313.04. ... Institutional Ownership. Headlines. Options Chain. SEC Filings. Short Interest. Social Media. how to activate proline laptop
What Is The Ownership Structure Like For Paratek …
Webb10 juli 2024 · The big shareholder groups in Paratek Pharmaceuticals, Inc. ( NASDAQ:PRTK) have power over the company. Institutions often own shares in more established companies, while it's not unusual to see... WebbCompany profile for Paratek Pharmaceuticals Inc. including key executives, insider trading, ownership, revenue and average growth rates. View detailed PRTK description & address. Webb13 apr. 2024 · Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies … metcalf compounding brevard